+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Gedeon Richter Plc (RICHTER) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 49 Pages
  • May 2024
  • GlobalData
  • ID: 1291958
Gedeon Richter Plc (RICHTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Gedeon Richter Plc (Richter) is a pharmaceutical company that develops, manufactures and markets a wide range of drugs including original, generic, and licensed products and over the counter (OTC) medicines. The company’s product portfolio consists of medicines to treat gynecological diseases, gastrointestinal diseases, cardiovascular diseases and central nervous system disorders. Richter’s research activities focus exclusively on the development of original small molecules, recombinant biotechnology, and generic product development. It operates sales network in Hungary, Central Eastern Europe, and the Commonwealth of Independent States (CIS) countries. The company has a research and development unit in Central Eastern Europe. Richter is headquartered in Budapest, Hungary.

Gedeon Richter Plc Key Recent Developments

  • Apr 10, 2024: New, Independent Supervisory Board and Audit Board Member Candidate at Richter Gedeon Nyrt
  • Mar 25, 2024: Gedeon Richter Selects Trial Interactive for Clinical Trial Management
  • Feb 29, 2024: Richter Reports Record Pharmaceutical Sales Revenue and Adjusted EBIT for 2023, Expects Further Growth in 2024

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Gedeon Richter Plc - Key Facts
  • Gedeon Richter Plc - Key Employees
  • Gedeon Richter Plc - Key Employee Biographies
  • Gedeon Richter Plc - Major Products and Services
  • Gedeon Richter Plc - History
  • Gedeon Richter Plc - Company Statement
  • Gedeon Richter Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Gedeon Richter Plc - Business Description
  • Business Segment: Other
  • Overview
  • Performance
  • Business Segment: Pharmaceuticals
  • Overview
  • Performance
  • Geographical Segment: APAC
  • Performance
  • Geographical Segment: China
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Latin America
  • Performance
  • Geographical Segment: North America
  • Performance
  • Geographical Segment: Other Countries
  • Performance
  • R&D Overview
  • Gedeon Richter Plc - Corporate Strategy
  • Gedeon Richter Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Gedeon Richter Plc - Strengths
  • Gedeon Richter Plc - Weaknesses
  • Gedeon Richter Plc - Opportunities
  • Gedeon Richter Plc - Threats
  • Gedeon Richter Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Gedeon Richter Plc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Gedeon Richter Plc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Gedeon Richter Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 10, 2024: New, Independent Supervisory Board and Audit Board Member Candidate at Richter Gedeon Nyrt
  • Mar 25, 2024: Gedeon Richter Selects Trial Interactive for Clinical Trial Management
  • Feb 29, 2024: Richter Reports Record Pharmaceutical Sales Revenue and Adjusted EBIT for 2023, Expects Further Growth in 2024
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Gedeon Richter Plc, Key Facts
  • Gedeon Richter Plc, Key Employees
  • Gedeon Richter Plc, Key Employee Biographies
  • Gedeon Richter Plc, Major Products and Services
  • Gedeon Richter Plc, History
  • Gedeon Richter Plc, Other Locations
  • Gedeon Richter Plc, Subsidiaries
  • Gedeon Richter Plc, Joint Venture
  • Gedeon Richter Plc, Key Competitors
  • Gedeon Richter Plc, Ratios based on current share price
  • Gedeon Richter Plc, Annual Ratios
  • Gedeon Richter Plc, Interim Ratios
  • Gedeon Richter Plc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Gedeon Richter Plc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Gedeon Richter Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Gedeon Richter Plc, Performance Chart (2019 - 2023)
  • Gedeon Richter Plc, Ratio Charts
  • Gedeon Richter Plc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Gedeon Richter Plc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Sinnex Plc
  • Sager Pharma Kft
  • Nutex Nyrt
  • EGIS Pharmaceuticals Plc